It relies on a "support team" of other nutrients to function properly
By targeting growth hormone signaling, peptide therapy helps improve metabolic function, accelerate muscle recovery, and support long-term wellness
As care becomes more integrated across gastroenterology, endocrinology and obesity medicine, these agents may help reduce steroid exposure and improve overall disease stability when used alongside standard Crohns therapies. An unexplored area Approximately half of patients with Crohns disease in the United States have obesity, according to study background
The high molecular homology of liraglutide to the native GLP-1(97% amino acid homology) with great protraction properties may explain the high prevalence of symptomatic cholelithiasis among liraglutide users (81.8%) than other GLP-1RAs [13, 14]
What we know about dosing comes from clinical trials
More recently, GLP-1s have been designed to target obesity, too